Integra LifeSciences Cor... (IART)
NASDAQ: IART
· Real-Time Price · USD
13.97
0.35 (2.57%)
At close: Aug 15, 2025, 12:26 PM
Integra LifeSciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.62B | 1.62B | 1.61B | 1.56B | 1.57B | 1.53B | 1.54B | 1.54B | 1.55B | 1.56B | 1.56B | 1.57B | 1.57B | 1.56B | 1.54B | 1.53B | 1.51B | 1.38B |
Cost of Revenue | 768.66M | 748.1M | 721.91M | 691.4M | 674.88M | 663.42M | 649.35M | 634.23M | 618.6M | 592.76M | 587.36M | 595.67M | 591.69M | 594.55M | 597.81M | 588.63M | 578.97M | 533.18M |
Gross Profit | 853.07M | 876.21M | 888.61M | 873.52M | 891.63M | 866.18M | 892.22M | 908.33M | 926.73M | 969.11M | 970.31M | 969.5M | 975.15M | 964.46M | 944.64M | 936.94M | 929.97M | 844.43M |
Operating Income | -500.69M | 47.23M | 66.69M | 86.95M | 121.69M | 98.94M | 131.36M | 143.32M | 181.78M | 229.14M | 238.92M | 229.3M | 220.69M | 212.68M | 197.23M | 191.65M | 192.75M | 154.98M |
Interest Income | 19.07M | 19.42M | 20.04M | 19.7M | 19.25M | 18.14M | 17.2M | 17.96M | 16.62M | 14.65M | 11.92M | 8.04M | 6.57M | 6.37M | 6.74M | 7.47M | 7.96M | 8.47M |
Pretax Income | -558.81M | -43.04M | -18.24M | -11.92M | 27.05M | 46.06M | 81.07M | 116.42M | 156.61M | 204.36M | 213.89M | 201.47M | 193.47M | 186.71M | 214.68M | 201.81M | 192.53M | 149.36M |
Net Income | -500.63M | -28.95M | -6.94M | -6.54M | 23.65M | 40.23M | 67.74M | 100.85M | 131.27M | 171.88M | 180.55M | 172.99M | 166.3M | 156.58M | 169.07M | 216.44M | 205.54M | 170.11M |
Selling & General & Admin | 704.84M | 697.14M | 681.44M | 650.36M | 647.37M | 640.1M | 640.95M | 645.43M | 627.3M | 623.05M | 616.32M | 626.65M | 638.84M | 640.74M | 637.45M | 637.59M | 631.65M | 585.21M |
Research & Development | 110.37M | 108.41M | 110.64M | 103.75M | 102.91M | 104.46M | 104.22M | 106.69M | 104.83M | 103.83M | 101.19M | 99.14M | 100.23M | 94.76M | 93.05M | 90.5M | 84.13M | 78.94M |
Other Expenses | 518.83M | 5.15M | 4.54M | -5.52M | -5.05M | -6.64M | -2.92M | 6.97M | 9.64M | 13.1M | 13.88M | 14.76M | 16.6M | 18.33M | 19.31M | 16.34M | 13.84M | 9.78M |
Operating Expenses | 1.35B | 825.27M | 821.92M | 786.57M | 769.94M | 767.24M | 760.86M | 765.01M | 744.95M | 739.98M | 731.39M | 740.2M | 754.45M | 751.78M | 747.41M | 745.29M | 737.22M | 689.45M |
Interest Expense | 40.58M | 38.19M | 70.63M | 65.4M | 59.09M | 52.9M | 51.38M | 50.52M | 50.27M | 50.04M | 49.59M | 48.83M | 48.21M | 49.12M | 50.4M | 55.62M | 64.22M | 66.76M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.56M | -3.56M | -3.56M |
Cost & Expenses | 2.12B | 1.58B | 1.54B | 1.48B | 1.44B | 1.43B | 1.41B | 1.4B | 1.36B | 1.33B | 1.32B | 1.34B | 1.35B | 1.35B | 1.35B | 1.33B | 1.32B | 1.22B |
Income Tax Expense | -58.18M | -14.09M | -11.29M | -5.38M | 3.4M | 5.83M | 13.33M | 15.57M | 25.34M | 32.48M | 33.34M | 28.48M | 27.16M | 30.13M | 45.6M | -14.63M | -13.01M | -20.75M |
Shares Outstanding (Basic) | n/a | 76.46M | 77.01M | 76.45M | 77.41M | 77.73M | 78.33M | 79.69M | 80.97M | 81.87M | 83.65M | 83.04M | 83.17M | 83.63M | 84.7M | 84.75M | 84.69M | 84.5M |
Shares Outstanding (Diluted) | n/a | 76.46M | 77.01M | 76.45M | 77.41M | 77.73M | 78.33M | 79.81M | 81.15M | 82.32M | 83.65M | 83.4M | 83.62M | 84.28M | 85.78M | 85.45M | 85.34M | 85.26M |
EPS (Basic) | -0.22 | -0.38 | -0.09 | -0.09 | 0.29 | 0.50 | 0.84 | 1.22 | 1.58 | 2.07 | 2.16 | 2.07 | 1.98 | 1.85 | 2.00 | 2.56 | 2.43 | 2.02 |
EPS (Diluted) | -0.22 | -0.38 | -0.09 | -0.09 | 0.29 | 0.50 | 0.83 | 1.21 | 1.57 | 2.06 | 2.16 | 2.06 | 1.97 | 1.84 | 1.98 | 2.54 | 2.41 | 2.00 |
EBITDA | -369.49M | 148M | 234.56M | 233.7M | 282.22M | 325.47M | 346.44M | 372.31M | 389.4M | 403.09M | 386.51M | 372.28M | 355.8M | 336.5M | 366.28M | 383.1M | 397.33M | 366.36M |
EBIT | -514.09M | -714K | 56.53M | 62.73M | 91.26M | 104.08M | 137.57M | 164.47M | 204.4M | 251.93M | 255.8M | 239.64M | 225.58M | 213.92M | 242.66M | 240.47M | 245.23M | 210.41M |
Depreciation & Amortization | 144.5M | 143.58M | 140.8M | 133.82M | 128.42M | 122.96M | 124.8M | 123.77M | 124.33M | 124.03M | 121.34M | 123.27M | 122.85M | 122.59M | 123.62M | 96.55M | 74.2M | 73.12M |